Trial reportHypertension (Dallas, Tex. : 1979)2021
Effect of Intensive Versus Standard Blood Pressure Control on Stroke Subtypes.
Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph
Trial report in Hypertension (Dallas, Tex. : 1979), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 5 citations in OpenAlex.
- Association between intensive blood pressure lowering and stroke-free survival among patients with and without Diabetes.Scientific reports · 2024Trial
- Review
- Optimal Blood Pressure Targets in the Early Stage of Cardioembolic Ischemic Stroke.Journal of stroke · 2025Article
- Systemic immune-inflammation index as a biomarker for stroke prognosis: insights from a multi-time point analysis.Biomarkers in medicine · 2025Article
- Optimal target blood pressure for the primary prevention of hemorrhagic stroke: a nationwide observational study.Frontiers in neurology · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors at 14 institutions in 1 country.
Clinton B WrightFrom the Division of Clinical Research, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD (C.B.W.).
Alexander P AuchusDepartment of Neurology, University of Mississippi Medical Center, Jackson (A.P.A.).
Alan LernerDepartment of Neurology, Case Western Reserve University, Cleveland, OH (A.L.).
Walter T AmbrosiusDepartment of Biostatistics and Data Science, Wake Forest School of Medicine, Winston-Salem, NC (W.T.A., J.J.W.).
Hakan AyDepartments of Neurology and Radiology, Massachusetts General Hospital, Harvard Medical School, Boston (H.A.).
Jeffrey T BatesMichael E. DeBakey Veterans Affairs Medical Center and Baylor College of Medicine, Houston, TX (J.T.B.).
Jing ChenDepartment of Medicine, Tulane School of Medicine, New Orleans, LA (J.C.).
James F MeschiaDepartment of Neurology, Mayo Clinic, Jacksonville, FL (J.F.M.).
Suchita PancholiDepartment of Medicine, University of South Carolina School of Medicine, Columbia (S.P.).
Vasilios PapademetriouDepartment of Medicine, Georgetown University School of Medicine, Washington, DC (V.P.).
Anjay RastogiDepartment of Medicine, UCLA School of Medicine, Los Angeles, CA (A.R.).
Mary SweeneyDepartment of Medicine, Emory University School of Medicine, Atlanta, GA (M.S.).
James J WillardDepartment of Biostatistics and Data Science, Wake Forest School of Medicine, Winston-Salem, NC (W.T.A., J.J.W.).
Jerry YeeDivision of Nephrology and Hypertension, Henry Ford Hospital, Detroit, MI (J.Y.).
Suzanne OparilDepartment of Medicine, University of Alabama at Birmingham (S.O.).
Wake Forest University · USCase Western Reserve University · USEmory University · USGeorgetown University · USHarvard University · USHenry Ford Hospital · USJackson Memorial Hospital · USMayo Clinic in Florida · USMichael E. DeBakey VA Medical Center · USNational Institutes of Health · USTulane University · USUniversity of Alabama at Birmingham · USUniversity of California, Los Angeles · USUniversity of South Carolina · US
Funding
INSTITUTIONAL CLINICAL AND TRANSLATIONAL SCIENCE AWARDUL1RR024134 · NCRR · UNIVERSITY OF PENNSYLVANIA · PI FITZGERALD, GARRET A · 2006 to 2011
$70.4MUniversity of Pittsburgh Clinical and Translational Science InstituteUL1TR000005 · NCATS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI REIS, STEVEN E · 2012 to 2015
$50.8MClinical and Translational Science Collaborative of ClevelandUL1TR000439 · NCATS · CASE WESTERN RESERVE UNIVERSITY · PI KONSTAN, MICHAEL W. · 2012 to 2016
$50.0MMichigan Institute for Clinical and Health Research (MCHR)UL1TR000433 · NCATS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MASHOUR, GEORGE ALEXANDER · 2012 to 2016
$49.9MStanford Center for Clinical & Translational Education and Research (Spectrum)UL1TR003142 · NCATS · STANFORD UNIVERSITY · PI O'HARA, RUTH M · 2019 to 2023
$45.0MThe Vanderbilt Institute for Clinical and Translational Research (VICTR)UL1TR000445 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BERNARD, GORDON RAPHAEL · 2012 to 2016
$41.4MInstitutional Clinical and Translational Science AwardUL1TR000003 · NCATS · UNIVERSITY OF PENNSYLVANIA · PI FITZGERALD, GARRET A · 2012 to 2015
$38.9MWake Forest Claude D. Pepper OAIC - RenewalP30AG021332 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Denise Kathryn Houston · 2002 to 2026
$36.4MClinical and Translational Science Collaborative of ClevelandUL1TR002548 · NCATS · CASE WESTERN RESERVE UNIVERSITY · PI MCCOMSEY, GRACE A · 2018 to 2022
$35.5MTufts Clinical and Translational Research InstituteUL1TR001064 · NCATS · TUFTS UNIVERSITY BOSTON · PI SELKER, HARRY P. · 2013 to 2017
$26.4MUniversity of Iowa Clinical and Translational Science Program (TL1)UL1RR025755 · NCRR · OHIO STATE UNIVERSITY · PI JACKSON, REBECCA D · 2008 to 2011
$26.3MUniversity of Alabama at Birmingham's Diabetes Research CenterP30DK079626 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Kirk Michael Habegger · 2013 to 2026
$19.5MIntramural NIH HHS Z99 NS999999NCATS NIH HHS UL1 TR000002NCATS NIH HHS UL1 TR000003NCATS NIH HHS UL1 TR000005NCATS NIH HHS UL1 TR000050NCATS NIH HHS UL1 TR000064NCATS NIH HHS UL1 TR000073NCATS NIH HHS UL1 TR000075NCATS NIH HHS UL1 TR000093NCATS NIH HHS UL1 TR000105NCATS NIH HHS UL1 TR000433NCATS NIH HHS UL1 TR000439NCATS NIH HHS UL1 TR000445NCATS NIH HHS UL1 TR001064NCATS NIH HHS UL1 TR002548NCATS NIH HHS UL1 TR003142NCRR NIH HHS UL1 RR024134NCRR NIH HHS UL1 RR025752NCRR NIH HHS UL1 RR025755NCRR NIH HHS UL1 RR025771NHLBI NIH HHS HHSN268200900040CNHLBI NIH HHS HHSN268200900046CNHLBI NIH HHS HHSN268200900047CNHLBI NIH HHS HHSN268200900048CNHLBI NIH HHS HHSN268200900049CNHLBI NIH HHS K01 HL133468NIA NIH HHS P30 AG021332NIA NIH HHS R01 AG055606NIDDK NIH HHS P30 DK079626NIGMS NIH HHS P30 GM103337NINDS NIH HHS K23 NS107645
Abstract
[Figure: see text].
Indexed as
Hemorrhagic StrokeHypertensionIschemic StrokeRisk AssessmentAgedAntihypertensive AgentsBlood Pressure DeterminationFemaleHeart Disease Risk FactorsHumansMaleMedication Therapy ManagementMiddle AgedOutcome and Process Assessment, Health CarePatient Care PlanningPreventive Health ServicesAntihypertensive Agentsatherosclerosisblood pressurehemorrhagic strokehypertensionischemic stroke
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.